Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.

已完结 10 由 123 发布于 2026/8/4 11:49:42

DOI:10.1001/jama.2026.7745
作者：Wenfeng Fang,?Yuanyuan Zhao,?Yongzhong Luo,?Runxiang Yang,?Yan Huang,?Zhiyong He,?Hui Zhao,?Mingjun Li,?Kai Li,?Qibin Song,?Xiaobo Du,?Yulan Sun,?Wei Li,?Longhua Sun,?Zhiyu Wang,?Kunning Yang,?Yun Fan
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1001/jama.2026.7745

JAMA

Abstract：Importance: Patients with epidermal growth factor receptor (EGFR) gene variant nonsquamous non-small cell lung cancer (NSCLC) who have disease progression after prior EGFR tyrosine kinase in

应助信息

1天前

谁说不是呢

523c31d88fb811f1924c34735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/8/4 11:49:42 未找到该文献，机器人已退出，请等待人工下载

2026/8/4 11:49:42 Book学术AI机器人收到请求，开始寻找文献

2026/8/4 11:49:42 已向机器人发送请求

1天前

123 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierStructural characterization and immune activity evaluation of a polysaccharide from Lyophyllum Decastes